Structure-skin permeability relationship of dendrimers

Pharmaceutical Research

Volumn 28, Issue 9, 2011, Pages 2246-2260

  Venuganti, Venkata Vamsi ^b   Sahdev, Preety ^a   Hildreth, Michael ^a   Guan, Xiangming ^a   Perumal, Omathanu ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Confocallaser scanning microscope; Dendrimer charge; Dendrimer generation; Iontophoresis; Nanocarrier

Indexed keywords

DENDRIMER; FLUORESCEIN ISOTHIOCYANATE; POLYAMIDOAMINE;

ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IN VITRO STUDY; IONTOPHORESIS; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STUDY; SKIN PENETRATION; SKIN STRUCTURE; SKINFOLD THICKNESS; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHROMATOGRAPHY, THIN LAYER; DENDRIMERS; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; IONTOPHORESIS; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; NYLONS; PARTICLE SIZE; PERMEABILITY; SKIN; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; SWINE;

EID: 80054774979     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0455-0     Document Type: Article

References (50)

1. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev. 1971;51:702-47.
2. Downing DT. Lipid and protein structure in the permeability barrier of mammalian epidermis. J Lipid Res. 1992;33:301-13.
3. Naik A, Kalia YN, Guy RH. Trbansdermal drug delivery: overcoming skin's barrier function. Pharm Sci Technol Today. 2000;3:318-26.
4. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115-24. (Pubitemid 38239773)
5. Venuganti VK, Perumal OP. Nanosystems for dermal and transdermal drug delivery. In: Pathak Y, Thassu D, editors. Nanoparticulate drug delivery systems: formulation and characterization. New York: Informa Health; 2009. p. 124-53.
6. Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release. 2010;141:277-99.
7. Esfand R, Tomalia DA. Poly (amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today. 2001;6:427-36. (Pubitemid 32328297)
8. Kannan RM, Perumal O, Kannan S. Dendrimers and hyperbranched polymers in drug delivery. In: Labhateswar V, Pelecky L, editors. Biomedical applications of nanotechnology. New Jersey: Wiley; 2005. p. 105-30.
9. Mammen M, Choi SK, Whitesides GM. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed. 1998;37:2754-94. (Pubitemid 29008561)
10. El-Sayed M, Ginski M, Rhodes C, Ghandehari H. Transepithelial transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release. 2002;81:355-65. (Pubitemid 34607155)
11. Bai S, Ahsan F. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin. Pharm Res. 2009;26:539-48.
12. Vandamme TF, Brobeck L. Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release. 2005;102:23-38. (Pubitemid 40093773)
13. Menjoge AR, Navath RS, Asad A, Kannan S, Kim CJ. Transport and biodistribution of dendrimers across human fetal membrane: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials. 2010;31:5007-21.
14. Kitchens KM, Kolhatkar RB, Swaan PW, Eddington NW, Ghandehari H. Transport of poly (amidoamine) dendrimers across caco-2 cell monolayers: influence of size, charge and fluorescent labeling. Pharm Res. 2006;23:2818-26. (Pubitemid 44885368)
15. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, et al. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Release. 2000;65:133-48. (Pubitemid 30122922)
16. El-Sayed M, Kiani MF, Naimark MD, Hikal AH, Ghandehari H. Extravasation of poly (amidoamine) (PAMAM) dendrimer across microvascular network endothelium. Pharm Res. 2001;18:23-8. (Pubitemid 32299618)
17. Dufe's C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv Drug Deliv Rev. 2005;57:2177-202. (Pubitemid 41759392)
18. Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, et al. Dendrimer mediated transdermal delivery: Enhanced bioavailability of indomethacin. J Control Release. 2003;90:335-43. (Pubitemid 36869009)
19. Venuganti VK, Perumal OP. Effect of poly (amidoamine) PAMAM dendrimer on the skin permeation of 5-fluorouracil. Int J Pharm. 2008;361:230-8.
20. Venuganti VK, Perumal OP. Poly (amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation and concentration. J Pharm Sci. 2009;98:2345-56.
21. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56:619-58. (Pubitemid 38326937)
22. Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, et al. Porcine ear skin, an in vitro model for human skin. Skin Res Technol. 2007;31:19-24. (Pubitemid 46152448)
23. Jevprasesphant R, Penny J, Attwood D, McKeown NB, D'Emanuele A. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res. 2003;20:1543-50. (Pubitemid 37268266)
24. Kalia YN, Pirot F, Guy RH. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophysical J. 1996;71:2692-700. (Pubitemid 26367731)
25. Diallo MS, Christie S, Swaminathan P, Balogh L, Shi X, Um W, et al. Dendritic chelating agents. 1. Cu (II) binding to ethylenediamine core poly (amidoamine) dendrimers in aqueous solutions. Langmuir. 2004;20:2640-51.
26. Rastogi SK, Singh J. Lipid extraction and transport of hydrophilic solutes through porcine epidermis. Int J Pharm. 2001;225:75-82. (Pubitemid 32728201)
27. Turner NG, Ferry L, Price M, Cullander C, Guy RH. Iontophoresis of poly-L-lysines: The role of molecular weight? Pharm Res. 1997;14:1322-133.
28. Do JH, Joun YS, Chung DJ. Cellular-uptake behavior of polymer nanoparticles into consideration of biosafety. Macromol Res. 2008;16:695-703.
29. Oh J, Choi S, Lee G, Kim J, Choy J. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin mediated endocytosis. Chem Asian J. 2009;4:67-73.
30. Lee JH, Lim Y, Choi S, Lee Y, Kim T, Kim HJ, et al. Polyplexes assembled with internally quartnized PAMAM-OH dendrimer and plasmid DNA have a neutral surface charge and gene delivery potency. Bioconjugate Chem. 2003;14:1214-21. (Pubitemid 37449052)
31. Nuha P, Davoren M, Lyng FM, Byrne HJ. Reactive oxygen species induced cytokine production and cytotoxicity of PAMAM dendrimers in J774a.1 cells. Toxicol Appl Pharmacol. 2010;246:91-9.
32. Alvarez-Roman R, Naik A, Kalia YN, Fessi H, Guy RH. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm. 2004;58:301-16. (Pubitemid 39037237)
33. Dubey S, Kalia YN. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. J Control Release. 2010;145:203-9.
34. Brus C, Santi P, Colombo P, Kissel T. Distribution and quantification of polyethyleneimine oligodeoxyneclotide complexes in human skin after iontophoretic delivery using confocal scanning laser microscopy. J Control Release. 2002;84:171-81. (Pubitemid 35439143)
35. Burnette RR, Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci. 1987;76:765-73.
36. Schuetz YB, Carrupt PA, Naik A, Guy RH, Kalia YN. Structurepermeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis. Eur J Pharm Sci. 2006;29:53-9. (Pubitemid 44294860)
37. Wu X, Landfester K, Musyanovych A, Guy RH. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol. 2010;23:117-23.
38. Perumal OP, Inapagolla R, Kannan S, Kannan RM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials. 2008;29:3469-76.
39. Marro D, Guy RH, Delgado-Charro MB. Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release. 2001;70:213-7. (Pubitemid 32144805)
40. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: electrorepulsion and electroosmosis. J Control Release. 2000;64:129-32. (Pubitemid 30035313)
41. Ruddy SB, Hadzija BW. Iontophoretic permeability of polyethylene glycols through hairless rat skin: application of hydrodynamic theory for hindered transport through liquid-filled pores. Drug Des Discov. 1992;8:207-24.
42. Pikal MJ, Shah S. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res. 1990;7:222-9. (Pubitemid 20228559)
43. Pillai O, Kumar N, Dey CS, Borkute, Sivaprasad N, Panchagnula R. Transdermal iontophoresis of insulin: III. Influence of electronic parameters. Methods: Find Exp Clin Pharmacol. 2004;26:399-408. (Pubitemid 39079106)
44. Cazares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN. Transdermal delivery of cytochrome-c, a 12-4 kDa protein across intact skin by constant current iontophoresis. Pharm Res. 2007;24:1360-8. (Pubitemid 46870601)
45. Kasting GB, Keister JC. Applications of electrodiffusion theory for a homogenous membrane to iontophoretic transport through skin. J Control Release. 1989;8:195-210. (Pubitemid 19098999)
46. Hirvonen J, Guy RH. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J Control Release. 1998;50:283-9. (Pubitemid 28044123)
47. Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9:663-9.
48. Abla N, Naik A, Guy RH, Kalia YN. Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharm Res. 2005;22:2069-78. (Pubitemid 41821586)
49. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99:53-62. (Pubitemid 39165733)
50. Prausnitz MR, Gimm JA, Guy RH, Langer R, Weaver JC, Cullander C. Imaging regions of transport across human stratum corneum during high-voltage and low-voltage exposures. J Pharm Sci. 1996;85:1363-70.